Clinical Trial Update: Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating temsirolimus with bevacizumab in hormone-resistant metastatic prostate cancer that failed chemotherapy has completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Temsirolimus (temsirolimus)
• bevazicumab (bevacizumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-21